Impact of Hormonal Therapy on Intermediate Risk Prostate Cancer Treated With Combination Brachytherapy and External Beam Irradiation EDITORIAL COMMENT

被引：0
|
作者：
Roach, Mack, III [1 ]
机构：
[1] Univ Calif San Francisco, Dept Radiat Oncol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 02期
关键词：
D O I：
10.1016/j.juro.2009.10.107
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：551 / 551
页数：1
相关论文
共 50 条
  • [31] Supplemental Androgen Deprivation Therapy Is More Beneficial Than Supplemental External Beam Radiation Therapy for Men with Unfavorable Intermediate Risk Prostate Cancer Treated with Brachytherapy
    King, M.
    Nguyen, P. L.
    Chen, M. H.
    Moran, B. J., Jr.
    Braccioforte, M. H.
    DAmico, A. V.
    Buzurovic, I.
    Devlin, P. M.
    Orio, P. F., III
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E247 - E247
  • [32] The impact of hormonal therapy when combined with external beam radiotherapy for early-stage intermediate-and high-risk prostate cancer
    Jani, AB
    Basu, A
    Connell III, PP
    Vijayakumar, S
    Abdalla, I
    RADIOLOGY, 2000, 217 : 213 - 213
  • [33] A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy
    Slevin, Finbar
    Rodda, Sree Lakshmi
    Bownes, Peter
    Murray, Louise
    Bottomley, David
    Wilkinson, Clare
    Adiotomre, Ese
    Al-Qaisieh, Bashar
    Dugdale, Emma
    Hulson, Oliver
    Mason, Joshua
    Smith, Jonathan
    Henry, Ann M.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 20 : 1 - 8
  • [34] Long-term Complications in Patient with Prostate Cancer Treated with Combination Brachytherapy, External Beam Radiation Therapy, and Hormone Ablation Therapy
    Friedman, I. E.
    Stone, N. N.
    Stock, R. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S516 - S517
  • [35] Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy Alone
    Andruska, Neal
    Fischer-Valuck, Benjamin W.
    Carmona, Ruben
    Agabalogun, Temitope
    Brenneman, Randall J.
    Gay, Hiram A.
    Michalski, Jeff M.
    Baumann, Brian C.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (04): : 343 - +
  • [36] PERMANENT BRACHYTHERAPY AS SALVAGE THERAPY FOR LOCALLY RECURRENT PROSTATE CANCER AFTER EXTERNAL BEAM IRRADIATION
    Vavassori, Andrea
    Cattani, Federica
    Fodor, Cristiana
    Gherardi, Federica
    Comi, Stefania
    Rondi, Elena
    Spoto, Ruggero
    Lazzari, Roberta
    Jereczek-Fossa, Barbara
    Zerini, Dario
    Dell'acqua, Veronica
    Cecconi, Agnese
    Decobelli, Ottavio
    Musi, Gennaro
    Scardino, Epifanio
    Matei, Victor
    Verweij, Fabrizio
    Orecchia, Roberto
    ANTICANCER RESEARCH, 2011, 31 (05) : 1901 - 1901
  • [37] Permanent brachytherapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation
    Vavassori, A.
    Spoto, R.
    Gherardi, F.
    Fodor, C.
    Cattani, F.
    Comi, S.
    Jereczek-Fossa, B. A.
    Zerini, D.
    Lazzari, R.
    Orecchia, R.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S153 - S153
  • [38] Quality of life in intermediate or high risk prostate cancer patients treated by external beam radiotherapy and brachytherapy with or without androgen deprivation
    Lacorte-Pi, T. M.
    Guix-Melcior, B.
    Guedea-Edo, F.
    PSYCHO-ONCOLOGY, 2006, 15 (02) : S296 - S297
  • [39] Editorial Comment to Impact of age on quality of life in patients with localized prostate cancer treated with high-dose rate brachytherapy combined with external beam radiotherapy
    Okihara, Koji
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (04) : 371 - 372
  • [40] Counterpoint: High-risk prostate cancer: The case for combination brachytherapy and external beam Irradiation Rebuttal to Dr. Stock
    Moul, Judd W.
    BRACHYTHERAPY, 2008, 7 (04) : 283 - 283
12345